INZOLI, ELENA
 Distribuzione geografica
Continente #
EU - Europa 343
AS - Asia 127
NA - Nord America 118
SA - Sud America 13
AF - Africa 7
OC - Oceania 1
Totale 609
Nazione #
IT - Italia 154
US - Stati Uniti d'America 115
SG - Singapore 64
RU - Federazione Russa 63
DE - Germania 40
CN - Cina 23
HK - Hong Kong 21
IE - Irlanda 16
FR - Francia 13
FI - Finlandia 12
ES - Italia 10
SE - Svezia 10
GB - Regno Unito 9
BR - Brasile 7
EG - Egitto 6
ID - Indonesia 5
IN - India 5
AR - Argentina 4
PL - Polonia 4
CA - Canada 3
AT - Austria 2
BE - Belgio 2
CZ - Repubblica Ceca 2
GR - Grecia 2
IR - Iran 2
KZ - Kazakistan 2
NO - Norvegia 2
PH - Filippine 2
AU - Australia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
EC - Ecuador 1
JP - Giappone 1
MA - Marocco 1
NL - Olanda 1
UA - Ucraina 1
VE - Venezuela 1
Totale 609
Città #
Milan 51
Singapore 42
Frankfurt am Main 28
Hong Kong 21
Dublin 16
Santa Clara 12
Ann Arbor 10
Ashburn 8
Los Angeles 8
Munich 8
Helsinki 7
Rome 7
Turin 7
Desio 6
New York 6
Chandler 5
Como 5
Hefei 5
Jakarta 5
St Petersburg 5
Delhi 4
San Jose 4
Chicago 3
Lissone 3
Lleida 3
Moscow 3
Shanghai 3
Tianjin 3
Almaty 2
Altamura 2
Athens 2
Beijing 2
Bologna 2
Bolzano 2
Boulogne-Billancourt 2
Brussels 2
Buenos Aires 2
Carate Brianza 2
Cesano Maderno 2
Council Bluffs 2
Genoa 2
Glendale 2
Guangzhou 2
L'Hospitalet de Llobregat 2
Lappeenranta 2
Lauterbourg 2
London 2
Manila 2
Marino 2
Milton Keynes 2
Monza 2
Málaga 2
Novara 2
Nuremberg 2
Oslo 2
Poznan 2
Princeton 2
Romano d'Ezzelino 2
Romola 2
Rovello Porro 2
Santa Cruz de Tenerife 2
Sesto San Giovanni 2
Spresiano 2
Sumirago 2
Tehran 2
Toronto 2
Treviglio 2
Turku 2
Veniano 2
Vienna 2
Vimodrone 2
Véretz 2
Zandobbio 2
Adelaide 1
Ahmedabad 1
Altivole 1
Arzano 1
Atlanta 1
Baku 1
Bari 1
Boardman 1
Bonn 1
Brno 1
Buffalo 1
Cachoeirinha 1
Cantu 1
Caraúbas 1
Carpi 1
Castelleone 1
Colorado 1
Dalmine 1
Edinburgh 1
Erba 1
Fairfield 1
Garbagnate Milanese 1
Giza 1
Hangzhou 1
Himeji 1
Houston 1
Huzhou 1
Totale 405
Nome #
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 200
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients 132
Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success 122
Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia 106
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis 36
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis Mimicking Triple Negative Myelofibrosis 32
Totale 628
Categoria #
all - tutte 2.829
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.829


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202220 0 0 0 0 0 0 0 0 0 0 0 20
2022/202383 10 16 5 2 4 6 3 7 18 9 1 2
2023/2024153 4 3 2 11 15 27 17 10 25 16 10 13
2024/2025372 13 37 29 28 32 18 26 13 45 81 49 1
Totale 628